Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Zindler

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2024
Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohortMichaël H Frank, Boukje A C van Dijk, Rosanne C Schoonbeek, et al.
Clinical and Translational Radiation Oncology|February 13, 2026
HYpofractionated, dose-redistributed RAdiotherapy (HYDRA) versus conventional radiotherapy for head and neck cancer: planned interim analysis and dosimetric comparison from the phase I HYDRA trialPascal A Gunsch, Michiel Kroesen, Reno Debets, et al.
BMC Cancer|June 13, 2023
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trialJoris B W Elbers, Pascal A Gunsch, Reno Debets, et al.
Frontiers in Oncology|June 6, 2018
Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future DirectionsDianne Hartgerink, Britt van der Heijden, Dirk De Ruysscher, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2020
Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 StudyEvert Jan Van Limbergen, Ann Hoeben, Relinde I Y Lieverse, et al.
Journal of Neuro-Oncology|December 29, 2025
Paradigm shift in patients with multiple brain metastases from whole brain radiotherapy to high precision multimodality treatment including stereotactic radiotherapyJeroen Crouzen, Mirjam Mast, Melissa Kerkhof, et al.
Neuro-Oncology Advances|March 19, 2021
A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastasesDianne Hartgerink, Anna Bruynzeel, Danielle Eekers, et al.
Annals of Palliative Medicine|November 22, 2021
Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trialDianne Hartgerink, Anna Bruynzeel, Danielle Eekers, et al.
Acta Oncologica (Stockholm, Sweden)|July 2, 2019
LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementationDianne Hartgerink, Ans Swinnen, David Roberge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2024
Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma - The Dutch approachDirk Wagenaar, Steven J M Habraken, Ilaria Rinaldi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2024
Differences in the association of time to treatment initiation and survival according to various head and neck cancer sites in a nationwide cohortMichaël H Frank, Boukje A C van Dijk, Rosanne C Schoonbeek, et al.
Clinical and Translational Radiation Oncology|February 13, 2026
HYpofractionated, dose-redistributed RAdiotherapy (HYDRA) versus conventional radiotherapy for head and neck cancer: planned interim analysis and dosimetric comparison from the phase I HYDRA trialPascal A Gunsch, Michiel Kroesen, Reno Debets, et al.
BMC Cancer|June 13, 2023
HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trialJoris B W Elbers, Pascal A Gunsch, Reno Debets, et al.
Frontiers in Oncology|June 6, 2018
Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future DirectionsDianne Hartgerink, Britt van der Heijden, Dirk De Ruysscher, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2020
Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 StudyEvert Jan Van Limbergen, Ann Hoeben, Relinde I Y Lieverse, et al.
Journal of Neuro-Oncology|December 29, 2025
Paradigm shift in patients with multiple brain metastases from whole brain radiotherapy to high precision multimodality treatment including stereotactic radiotherapyJeroen Crouzen, Mirjam Mast, Melissa Kerkhof, et al.
Neuro-Oncology Advances|March 19, 2021
A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastasesDianne Hartgerink, Anna Bruynzeel, Danielle Eekers, et al.
Annals of Palliative Medicine|November 22, 2021
Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trialDianne Hartgerink, Anna Bruynzeel, Danielle Eekers, et al.
Acta Oncologica (Stockholm, Sweden)|July 2, 2019
LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementationDianne Hartgerink, Ans Swinnen, David Roberge, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2024
Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma - The Dutch approachDirk Wagenaar, Steven J M Habraken, Ilaria Rinaldi, et al.
Pageof 3